World Human Growth Hormone Market Gains Traction, States Koncept Analytics in Its In-demand Report Available at MarketPublishers.com
09 Feb 2017 • by Natalie Aster
LONDON – Growth hormone (GH)/human growth hormone (hGH) holds responsibility for keeping control over the normal growth and development of a human specifically amid the children and teenagers. Despite giving an impetus to cell growth and keeping muscle mass, hGH also induces the liver to generate IGF-l which, in its turn, regulates the metabolism of muscles, osteocytes and tissues.
The deficiency of growth hormone (GH)/human growth hormone (hGH) – growth hormone deficiency (GHD) – is a medical problem that affects both children and adults. Amongst kids, GHD can be attributed to congenital defects, like marred pituitary development and other genetic disorders. While GHD amongst grow-ups is allegedly associated with pituitary gland tumours and it usually has nonspecific symptoms, like weight gain, reduced levels of energy, sleep disorder, and emotional distress.
Worldwide, the hGH market is gathering pace, fuelled by development and entry of long-acting medications, surging cancer and HIV/AIDS cases, increased incidence rates of GHD and other related disorders. A hike in healthcare spending and an increase in consumer buying power are also driving the market growth.
However, expensiveness of drugs, unapproved uses of hGH drug products and side effects pertaining to rhGH could pose a challenged to the sector’s growth.
In-demand report “Global Human Growth Hormone (hGH) Market: Industry Analysis & Outlook (2017-2021)” elaborated by Koncept Analytics is designed to give an up-close analysis of the development of the market on a global level, with focus on the country and regional markets such as the USA, Japan and Europe. It discusses prevalent trends, market growth drivers and challenges alongside various burning issues the market is facing. The study explores the competitive scenario and profiles the top 4 players in tandem with their key financials and growth strategies. The report provides granular market segmentation by indication; and offers market value and volume estimates plus forecasts.
Top companies examined are: Pfizer Inc., Eli Lilly, Novartis AG. and Company and Novo Nordisk A/S.
To find more market research reports by the publisher please follow Koncept Analytics page at MarketPublishers.com.